Polyps
Discrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.
Subtype terms (2)
More specific conditions that are subtypes of Polyps in the MeSH hierarchy.
- Intestinal Polyps
13 drugs (9 approved, 4 experimental)
- Nasal Polyps
41 drugs (31 approved, 10 experimental)
Drugs by status
Phase 4 trials (6)
Phase 3 trials (4)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (27)
- Regeneron
- Bristol-Myers Squibb
- Roche
- AstraZeneca
- Merck
- Sanofi
- Novartis
- GlaxoSmithKline
- Intersect ENT
- OptiNose AS
- National Cancer Institute (NCI)
- University of Arizona
- University of London
- Dartmouth University
- Eastern Virginia Medical School
- LifeBridge Health
- Capital Medical University
- The Spectrum Health Group
- Humanitas University
- Beijing Institute of Otolaryngology
- Magna Graecia University
- Advanced ENT and Allergy
- SLA Pharma
- BioClinica, Inc.
- Deltex Medical, Inc.
- Signant Health
- Universitarios de Xochicalco
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (4)